NASDAQ · IFRX
InflaRx N.V financials
$1.85+1.65%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 | Q4 '20 Dec 31 | Q4 '19 Dec 31 | Q4 '18 Dec 31 | Q4 '17 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — | — |
| Diluted shares | 67.3M | 58.9M | 54.9M | 44.2M | 41.6M | 27.1M | 26.0M | 25.1M | 9.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.8M | $19.1M | $14.1M | $16.3M | $29.9M | $31.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $64.8M | $79.1M | $132.9M | $102.4M | $142.3M | $107.4M |
| Total liabilities | $16.0M | $15.2M | $19.5M | $14.1M | $22.6M | $12.6M |
| Shareholders' equity | $48.8M | $63.9M | $113.4M | $88.3M | $119.7M | $94.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology